Fort Worth Diagnostics Unveils Innovative Measles Primer Set Amid Rising Cases

Fort Worth Diagnostics Introduces Measles Primer Set

Fort Worth Diagnostics (FWDX), a key player in the diagnostic assay market, announced the launch of its new Measles Primer Set on March 13, 2025. This significant development comes at a crucial time as the Centers for Disease Control and Prevention (CDC) reports over 222 cases of measles across 12 states, highlighting the urgent need for enhanced diagnostic tools.

The Measles Primer Set is designed to work seamlessly with both quantitative Polymerase Chain Reaction (qPCR) and digital PCR platforms. By utilizing advanced in-silica analytics, FWDX ensures high accuracy in measurement, making it a reliable choice for laboratories. The company implemented digital PCR technology to guarantee precision and consistency, which are vital for accurate diagnostics.

Product Details

Available in two different fill volumes—600 µL and 192 µL—the Measles Primer Set boasts a lengthy shelf life of 24 months. Each set is produced under current Good Manufacturing Practices (cGMP) in an FDA-registered facility, ensuring that they meet stringent regulatory standards. This commitment to quality is underscored by the extensive experience of the FWDX team, which collectively holds over 30 years in clinical diagnostics.

Jerry Boonyaratanakornkit, a scientist at Fort Worth Diagnostics, remarked, “We are proud to offer this critical Measles Virus Primer Set during such an important time.” His statement reflects the company’s dedication to supporting public health initiatives by providing vital tools for disease detection and control.

Addressing a Growing Concern

The spike in measles cases is concerning, particularly as the disease can lead to severe complications, including pneumonia and inflammation of the brain. Public health experts stress the importance of timely diagnosis and intervention. The Measles Primer Set is expected to enhance the capabilities of healthcare providers in testing and managing measles infections more effectively.

As part of its mission, Fort Worth Diagnostics prioritizes customer satisfaction and aims to advance the fields of Digital PCR and Quantitative PCR. The company's innovative offerings, like the Measles Primer Set, are designed to empower healthcare professionals with the highest quality reagents to optimize patient outcomes.

Looking Ahead

As measles cases rise, the introduction of FWDX's Measles Primer Set represents a proactive step towards combating this public health challenge. Laboratories and healthcare providers can expect to benefit from the reliability and precision of this new product, which promises to contribute significantly to disease management and control efforts nationwide.

For more information, interested parties can reach out to Fort Worth Diagnostics via their contact number 817-435-8511 or email at [email protected]. This launch not only signifies a technological advancement in the world of diagnostics but also underscores Fort Worth Diagnostics' commitment to enhancing public health through innovative solutions.